We find GTCpFE to effectively inhibit NFκB activation in a breast cancer subtype-independent manner demonstrated in multiple breast cancer cell lines and the intrinsic NFκB activity essential for CSCs. The gene discussed is NFKB1; the disease is breast carcinoma.